✦ LIBER ✦

Sodium Valproate in the Induction of Unusual Hepatotoxicity

✍ Scribed by Elie S. Zafrani; Pierre Berthelot

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 286 KB
Volume: 2
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840020520

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnosis of Parkinsonism in older patie

Diagnosis of Parkinsonism in older patients receiving sodium valproate

✍ Graeme J.A. Macphee; David A. Stewart 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Distribution of sodium valproate and gab

Distribution of sodium valproate and gaba metabolism in cns of the rat

✍ Claude Hariton; Lucien Ciesielski; Simone Simler; Marc Valli; Guy Jadot; Serge G 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 272 KB 👁 2 views

The distribution of VPA has been investigated in several brain areas of the rat, and GABA increases were measured. A biphasic exponential decay was observed for VPA; the slowest decrease was noted in the olfactory bulbs and in the hypothalamus where GAD and GABA-T activities were the highest. The da

Solid-State Forms of Sodium Valproate, A

Solid-State Forms of Sodium Valproate, Active Component of the Anticonvulsant Drug Epilim

✍ Gjorgi Petruševski; Panče Naumov; Gligor Jovanovski; Gordana Bogoeva-Gaceva; Sei 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 662 KB

Unusual products in the reactions of hex

Unusual products in the reactions of hexachlorocyclotriphosphazatriene with sodium aryloxides

✍ Adem Kiliç; Saliha Begeç; Bekir Çetinkaya; Tuncer Hökelek; Zeynel Kiliç; Necla G 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Reactions of hexachlorocyclotriphosphazatriene, N,P,CI, 1, with sodium aryloxides have been studied. Compound 1 was found to react by the nucleophilic substitution pathway to yield monocyclophosphazenes [N,P3Cl,4,6) 5 and N3P3CI4(OC6H2 Me-4-Bui-2,6), 61 and bi(cyc1ophosphazenes) Phosphorus-Nitrogen

Polymerase γ Gene POLG determines the ri

Polymerase γ Gene POLG determines the risk of sodium valproate-induced liver toxicity

✍ Joanna D. Stewart; Rita Horvath; Enrico Baruffini; Iliana Ferrero; Stefanie Buls 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 321 KB

Sodium valproate (VPA) is widely used throughout the world to treat epilepsy, migraine, chronic headache, bipolar disorder, and as adjuvant chemotherapy. VPA toxicity is an uncommon but potentially fatal cause of idiosyncratic liver injury. Rare mutations in POLG, which codes for the mitochondrial D

Influence of food intake on the pharmaco

Influence of food intake on the pharmacokinetics of a sustained release formulation of sodium valproate

✍ Marie-Jose Royer-Morrot; Azzedine Zhiri; Francine Jacob; Jose Necciari; Francois 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 2 views

## Abstract The effect of food intake on the pharmacokinetics of DEPAKINE® CHRONO 500 mg (Sanofi, France), a sustained release formulation containing 333 mg sodium valproate and 145 mg valproic acid, was studied in 12 young healthy female volunteers. Relative to fasting conditions (F), when the tab